‘Business of science’ digest—November 2020

Abstract

In our second monthly digest of ‘business of science’ articles from Springer Nature research journals, magazines and supplements, we delve into the history of cystic fibrosis research, celebrate two Nobel prize–winning CRISPR gene editing pioneers and examine big pharma’s interest in antibody–drug conjugates and exosomes. In our second monthly digest of ‘business of science’ articles from Springer Nature research journals, magazines and supplements, we delve into the history of cystic fibrosis research, celebrate two Nobel prize–winning CRISPR gene editing pioneers and examine big pharma’s interest in antibody–drug conjugates and exosomes.